Startseite Preoperative breast MRI-examination for all patients with histologically proven breast cancer? A concept for a prospective multicenter trial
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Preoperative breast MRI-examination for all patients with histologically proven breast cancer? A concept for a prospective multicenter trial

  • Christina Kaiser EMAIL logo , Christina Kehrer EMAIL logo , Mignon-Denise Keyver-Paik , Thomas Hecking , Tiyasha Hosne Ayub , Claudia Leutner , Hans Schild und Walther Kuhn
Veröffentlicht/Copyright: 11. November 2017
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background

A published retrospective data of our study group demonstrated that premenopausal women, patients with lobular invasive breast cancer or patients with high breast density [American College of Radiology (ACR) classification 3+4] significantly benefit from magnetic resonance imaging (MRI) leading to additional detection of malignant foci of 20.2% in the index and 2.5% in the contralateral breast, which would otherwise not be detected by routine imaging. Critics of preoperative MRI focus on higher false-positive rates leading to unnecessary surgical procedures and mastectomies. Therefore, MRI in preoperative imaging remains controversial.

Methods

To validate our retrospective data we initiate a prospective one-armed multicenter trial for patients with histologically confirmed breast cancer performing routine imaging by ultrasound and mammography followed by MRI imaging based on menopause status, histologic subtype, ACR and Breast Imaging Reporting and Data System (BIRADS)-classification. Primary endpoint is the rate of additional findings and change of treatment strategy, secondary endpoints are local recurrence-free, distant recurrence-free and overall survival. Additional MRI findings are calculated to be above 10% with a number of 100 patients recruited and a power of 80%.

Conclusion

MRI is detecting more tumor foci than conventional imaging but remains controversial in primary breast cancer for preoperative imaging because of the fear of over-diagnosis and the increased morbidity of additional potentially unnecessary surgical procedures. This planned one-armed prospective multicenter trial is designed to confirm our retrospectively revealed data defining subgroups with significant benefit of preoperative MRI to come to a consensus avoiding over-diagnosis and false-positive results leading to clinically beneficial and cost-effective use of preoperative MRI.

Author Statement

  1. Research funding: Authors state no funding involved.

  2. Conflict of interest: Authors had no conflict of financial or other interest.

  3. Informed consent: Informed consent is not applicable.

  4. Ethical approval: The conducted research is not related to either human or animals use.

References

[1] Wapnir IL, Anderson SJ, Mamounas EP, Geyer CE, Jr., Jeong JH, Tan-Chiu E, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five national surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006;24:2028–37.10.1200/JCO.2005.04.3273Suche in Google Scholar PubMed

[2] Wapnir IL, Gelber S, Anderson SJ, Mamounas EP, Robidoux A, Martin M, on behalf of CALOR trial investigators. et al. Poor prognosis after second locoregional recurrences in the CALOR trial. Ann Surg Oncol. 2017;24:398–406.10.1245/s10434-016-5571-ySuche in Google Scholar PubMed PubMed Central

[3] Guarneri V, Conte PF. The curability of breast cancer and the treatment of advanced disease. Eur J Nucl Med Mol Imaging. 2004;31:S149–61.10.1007/s00259-004-1538-5Suche in Google Scholar PubMed

[4] Krammer J, Pinker-Domenig K, Robson ME, Gonen M, Bernard-Davila B, Morris EA, et al. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2017;163:565–71.10.1007/s10549-017-4198-4Suche in Google Scholar PubMed PubMed Central

[5] Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23:8469–76.10.1200/JCO.2004.00.4960Suche in Google Scholar PubMed

[6] Houssami N, Turner R, Morrow M. Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg. 2013;257:249–55.10.1097/SLA.0b013e31827a8d17Suche in Google Scholar PubMed

[7] Morrow M, Harris JR. More mastectomies: is this what patients really want? J Clin Oncol. 2009;27:4038–40.10.1200/JCO.2009.23.0078Suche in Google Scholar PubMed

[8] Orel S. Who should have breast magnetic resonance imaging evaluation? J Clin Oncol. 2008;26:703–11.10.1200/JCO.2007.14.3594Suche in Google Scholar PubMed

[9] Debald M, Abramian A, Nemes L, Dobler M, Kaiser C, Keyver-Paik MD, et al. Who may benefit from preoperative breast MRI? A single-center analysis of 1102 consecutive patients with primary breast cancer. Breast Cancer Res Treat. 2015;153:531–7.10.1007/s10549-015-3556-3Suche in Google Scholar PubMed

[10] Houssami N, Hayes DF. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin. 2009;59:290–302.10.3322/caac.20028Suche in Google Scholar PubMed

[11] Gonzalez V, Sandelin K, Karlsson A, Aberg W, Lofgren L, Iliescu G, et al. Preoperative MRI of the breast (POMB) influences primary treatment in breast cancer: a prospective, randomized, multicenter study. World J Surg. 2014;38:1685–93.10.1007/s00268-014-2605-0Suche in Google Scholar

[12] Turnbull L, Brown S, Harvey I, Olivier C, Drew P, Napp V, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet. 2010;375:563–71.10.1016/S0140-6736(09)62070-5Suche in Google Scholar

[13] Peters NH, van Esser S, van den Bosch MA, Storm RK, Plaisier PW, van Dalen T, et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET – randomised controlled trial. Eur J Cancer. 2011;47:879–86.10.1016/j.ejca.2010.11.035Suche in Google Scholar PubMed

[14] Bruck N, Koskivuo I, Bostrom P, Saunavaara J, Aaltonen R, Parkkola R. Preoperative magnetic resonance imaging in patients with stage I invasive ductal breast cancer: a prospective randomized study. Scand J Surg. 2017:1457496917701669.10.1177/1457496917701669Suche in Google Scholar PubMed

Received: 2017-6-11
Accepted: 2017-9-6
Published Online: 2017-11-11

©2017 Walter de Gruyter GmbH, Berlin/Boston

Heruntergeladen am 25.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/hmbci-2017-0041/html
Button zum nach oben scrollen